Doreen Ibrahim Pamba is a seasoned Research Officer at the National Institute for Medical Research (NIMR). Doreen has worked at the NIMR-Mbeya Centre since 2010 and transitioned to the NIMR Muhimbili Centre in 2025. She has a degree in Political Science and Sociology (majoring in Medical Sociology) from the University of Dar Es Salaam and a Masters of Philosophy in International Health from the University of Bergen in Norway.

She has coordinated community engagement activities at the NIMR-Mbeya Centre for 15 years, which relate primarily to HIV, TB, and EBOLA clinical trials. In particular, Ms Pamba has coordinated these activities in 9 HIV vaccine trials, 8 TB drug trials, and 1 EBOLA vaccine trial. Furthermore, she has experience in regulatory work and QA/QC activities where she had oversight on monitoring ethical and regulatory aspects, as well as day-to-day quality control activities of trials implemented at the NIMR-Mbeya Centre. Professionally, she has led or contributed to numerous high-impact research studies funded by entities such as the EDCTP2, the Global Fund, USAID, and the CDC. She currently serves as Study Coordinator, Co-Principal Investigator, Community Engagement Lead, or Qualitative Lead in several projects. She has held leadership roles at NIMR-Mbeya, including Head of Social Science and Community Engagement and Project Manager. Doreen has authored multiple peer-reviewed publications, presented at global scientific forums, and serves on national technical committees, including the National TB and Leprosy Secretariat.

Ms Pamba is competent in the conduct of qualitative research as well as in mixed methods TB, HIV, HPV, and COVID-19 implementation research. She participates in grant writing activities and the coordination of their implementation as a project manager. Her research interests span implementation science, qualitative health systems research, HIV prevention, TB care, vaccine acceptability, and gender equity in public health programming. Ms Pamba, together with NIMR-Mbeya colleagues, has experience working collaboratively with TB/HIV/immunization policy makers at the national level. In particular, she assumed a leading role in advocating for the inclusion of HIV Vaccine-Induced Seropositivity (VISP) in the 2019 National HIV Testing and Services Guidelines. This has supported health facilities in procedures to manage HIV testing services among HIV vaccinees at the NIMR-centre and countrywide.